SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Piramal Pharma Solutions, NP2 To Complete Cyclophosphamide Development Phase Next Month

Piramal Pharma Solutions and NP2 are set to complete the development phase of Cyclophosphamide next month.